SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-24-017478
Filing Date
2024-10-11
Accepted
2024-10-11 16:02:13
Documents
1
Group Members
OCTAGON INVESTMENTS MASTER FUND LPTING JIA

Document Format Files

Seq Description Document Type Size
1 crbp1011241sc13g.htm SC 13G 67089
  Complete submission text file 0001214659-24-017478.txt   68831
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Subject) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88716 | Film No.: 241367542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065
Business Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065 212-369-2829
Octagon Capital Advisors LP (Filed by) CIK: 0001839435 (see all company filings)

IRS No.: 843576791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G